HIV-1 Subtype C, Tenofovir, and the Relationship With Treatment Failure and Drug Resistance

about

An association between K65R and HIV-1 subtype C viruses in patients treated with multiple NRTIs.

P2860

Q55340159-0DBE8FBB-449B-4771-81A1-B8E18A220603

P2860

HIV-1 Subtype C, Tenofovir, and the Relationship With Treatment Failure and Drug Resistance

Item

http://www.wikidata.org/entity/Q42380140

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

HIV-1 Subtype C, Tenofovir, an ...... nt Failure and Drug Resistance

@en

HIV-1 Subtype C, Tenofovir, an ...... nt Failure and Drug Resistance

@nl

type

Item

label

HIV-1 Subtype C, Tenofovir, an ...... nt Failure and Drug Resistance

@en

HIV-1 Subtype C, Tenofovir, an ...... nt Failure and Drug Resistance

@nl

prefLabel

HIV-1 Subtype C, Tenofovir, an ...... nt Failure and Drug Resistance

@en

HIV-1 Subtype C, Tenofovir, an ...... nt Failure and Drug Resistance

@nl

P1476

HIV-1 Subtype C, Tenofovir, an ...... nt Failure and Drug Resistance

@en

P2093

Alexandra U Scherrer

http://www.w3.org/2001/XMLSchema#string

P2860

Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis

Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

Virological failure in patients with HIV-1 subtype C receiving antiretroviral therapy: an analysis of a prospective national cohort in Sweden

Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial.

A review of the virological efficacy of the 4 World Health Organization-recommended tenofovir-containing regimens for initial HIV therapy.

HIV-1 subtype is an independent predictor of reverse transcriptase mutation K65R in HIV-1 patients treated with combination antiretroviral therapy including tenofovir

Sustainable HIV treatment in Africa through viral-load-informed differentiated care.

High rate of K65R for antiretroviral therapy-naive patients with subtype C HIV infection failing a tenofovir-containing first-line regimen

No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom.

Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis.

P304

1289-1291

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1093/INFDIS/JIW214

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

214

http://www.w3.org/2001/XMLSchema#string

P50

Huldrych F Günthard

P577

2016-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27869617

http://www.w3.org/2001/XMLSchema#string

P932

5079362

http://www.w3.org/2001/XMLSchema#string

HIV-1 Subtype C, Tenofovir, and the Relationship With Treatment Failure and Drug Resistance

about

P2860

P2860

HIV-1 Subtype C, Tenofovir, and the Relationship With Treatment Failure and Drug Resistance

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932